Literature DB >> 34487301

Targeting Mitochondrial Oxidative Phosphorylation in Glioblastoma Therapy.

Zhihao Wu1, Winson S Ho2, Rongze Lu3.   

Abstract

As a multi-functional cellular organelle, mitochondrial metabolic reprogramming is well recognized as a hallmark of cancer. The center of mitochondrial metabolism is oxidative phosphorylation (OXPHOS), in which cells use enzymes to oxidize nutrients, thereby converting the chemical energy to the biological energy currency ATPs. OXPHOS also creates the mitochondrial membrane potential and serve as the driving force of other mitochondrial metabolic pathways and experiences significant reshape in the different stages of tumor progression. In this minireview, we reviewed the major mitochondrial pathways that are connected to OXPHOS and are affected in cancer cells. In addition, we summarized the function of novel bio-active molecules targeting mitochondrial metabolic processes such as OXPHOS, mitochondrial membrane potential and mitochondrial dynamics. These molecules exhibit intriguing preclinical and clinical results and have been proven to be promising antitumor candidates in recent studies.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Glioblastoma; Mitochondrial dysfunction; OXPHOS inhibitors

Mesh:

Year:  2021        PMID: 34487301     DOI: 10.1007/s12017-021-08678-8

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  21 in total

1.  Mitochondrial fusion in human cells is efficient, requires the inner membrane potential, and is mediated by mitofusins.

Authors:  Frédéric Legros; Anne Lombès; Paule Frachon; Manuel Rojo
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

2.  Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies.

Authors:  Romain Guièze; Vivian M Liu; Daniel Rosebrock; Alexis A Jourdain; María Hernández-Sánchez; Aina Martinez Zurita; Jing Sun; Elisa Ten Hacken; Kaitlyn Baranowski; Philip A Thompson; Jin-Mi Heo; Zachary Cartun; Ozan Aygün; J Bryan Iorgulescu; Wandi Zhang; Giulia Notarangelo; Dimitri Livitz; Shuqiang Li; Matthew S Davids; Anat Biran; Stacey M Fernandes; Jennifer R Brown; Ana Lako; Zoe B Ciantra; Matthew A Lawlor; Derin B Keskin; Namrata D Udeshi; William G Wierda; Kenneth J Livak; Anthony G Letai; Donna Neuberg; J Wade Harper; Steven A Carr; Federica Piccioni; Christopher J Ott; Ignaty Leshchiner; Cory M Johannessen; John Doench; Vamsi K Mootha; Gad Getz; Catherine J Wu
Journal:  Cancer Cell       Date:  2019-09-19       Impact factor: 31.743

3.  Oxidative Metabolism Drives Immortalization of Neural Stem Cells during Tumorigenesis.

Authors:  François Bonnay; Ana Veloso; Victoria Steinmann; Thomas Köcher; Merve Deniz Abdusselamoglu; Sunanjay Bajaj; Elisa Rivelles; Lisa Landskron; Harald Esterbauer; Robert P Zinzen; Juergen A Knoblich
Journal:  Cell       Date:  2020-09-10       Impact factor: 41.582

4.  Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis.

Authors:  Ralph J DeBerardinis; Anthony Mancuso; Evgueni Daikhin; Ilana Nissim; Marc Yudkoff; Suzanne Wehrli; Craig B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-21       Impact factor: 11.205

5.  Verteporfin inhibits oxidative phosphorylation and induces cell death specifically in glioma stem cells.

Authors:  Kenta Kuramoto; Masahiro Yamamoto; Shuhei Suzuki; Tomomi Sanomachi; Keita Togashi; Shizuka Seino; Chifumi Kitanaka; Masashi Okada
Journal:  FEBS J       Date:  2020-01-09       Impact factor: 5.542

6.  Licochalcone A specifically induces cell death in glioma stem cells via mitochondrial dysfunction.

Authors:  Kenta Kuramoto; Shuhei Suzuki; Hirotsugu Sakaki; Hiroyuki Takeda; Tomomi Sanomachi; Shizuka Seino; Yoshitaka Narita; Takamasa Kayama; Chifumi Kitanaka; Masashi Okada
Journal:  FEBS Open Bio       Date:  2017-05-08       Impact factor: 2.693

Review 7.  The Role of Mitochondrial H+-ATP Synthase in Cancer.

Authors:  Pau B Esparza-Moltó; José M Cuezva
Journal:  Front Oncol       Date:  2018-03-07       Impact factor: 6.244

Review 8.  Mitochondrial Dysfunction in Gliomas: Pharmacotherapeutic Potential of Natural Compounds.

Authors:  Lalita Guntuku; V G M Naidu; Veera Ganesh Yerra
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

9.  Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs).

Authors:  Marco Fiorillo; Rebecca Lamb; Herbert B Tanowitz; Anna Rita Cappello; Ubaldo E Martinez-Outschoorn; Federica Sotgia; Michael P Lisanti
Journal:  Aging (Albany NY)       Date:  2016-08       Impact factor: 5.682

10.  Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells.

Authors:  Marco Fiorillo; Rebecca Lamb; Herbert B Tanowitz; Luciano Mutti; Marija Krstic-Demonacos; Anna Rita Cappello; Ubaldo E Martinez-Outschoorn; Federica Sotgia; Michael P Lisanti
Journal:  Oncotarget       Date:  2016-06-07
View more
  3 in total

1.  Synthesis, Characterization and Antitumor Mechanism Investigation of Heterometallic Ru(Ⅱ)-Re(Ⅰ) Complexes.

Authors:  Xiurong Ma; Junjian Lu; Peixin Yang; Bo Huang; Rongtao Li; Ruirong Ye
Journal:  Front Chem       Date:  2022-05-27       Impact factor: 5.545

2.  Combination of Ascorbic Acid and Menadione Induces Cytotoxic Autophagy in Human Glioblastoma Cells.

Authors:  Ana Despotović; Aleksandar Mirčić; Sonja Misirlić-Denčić; Ljubica Harhaji-Trajković; Vladimir Trajković; Nevena Zogović; Gordana Tovilović-Kovačević
Journal:  Oxid Med Cell Longev       Date:  2022-03-23       Impact factor: 6.543

3.  The Combination of Δ9-Tetrahydrocannabinol and Cannabidiol Suppresses Mitochondrial Respiration of Human Glioblastoma Cells via Downregulation of Specific Respiratory Chain Proteins.

Authors:  Anne Rupprecht; Ulrike Theisen; Franziska Wendt; Marcus Frank; Burkhard Hinz
Journal:  Cancers (Basel)       Date:  2022-06-27       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.